Navigation Links
TorreyPines Therapeutics Reports Third Quarter 2007 Results
Date:11/14/2007

ely to change and speak only as of the date hereof.

(Tables Follow)

TorreyPines Therapeutics, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

September 30, December 31,

2007 2006

(Unaudited)

Assets

Current assets

Cash and cash equivalents $39,723 $55,383

Prepaid expenses and other current assets 289 581

Total current assets 40,012 55,964

Long-term assets 7,025 7,471

Total assets $47,037 $63,435

Liabilities and stockholders' equity

Current liabilities $8,745 $12,270

Debt and other long-term liabilities 1,871 4,413

Deferred revenue 2,083 2,183

Total liabilities 12,699 18,866

Total stockholders' equity 34,338 44,569

Total liabilities and stockholders' equity $47,037 $63,435

TorreyPines Therapeutics, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(Unaudited)

Three months ended Nine months ended

September 30, September 30,

2007 2006 2007 2006

Revenue $2,463 $2,463 $7,388 $7,388

Operating expenses:

Resea
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... England , July 29, 2015  Indivior PLC ... (NDA) for naloxone nasal spray was accepted and received ... (FDA) for the treatment of opioid overdose. This naloxone ... naloxone specially formulated for optimal absorption into the nasal ... require minimal training so individuals may be better equipped ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is ... services. The core expertise of PRC Clinical is focused on Clinical Trial Management, ...
(Date:7/29/2015)... ... 2015 , ... Nearly everyone has heard of the potential of stem cells ... rich source of these cells is teeth—baby teeth that come loose during childhood, wisdom ... to make room for braces. These potent stem cells exist in the dental ...
(Date:7/28/2015)... , July 28, 2015 People with a ... aids achieved significant and sometimes profound improvements in their ... devices, according to a new multicenter study led by ... the study, described online ahead of print in the journal ... and private clinics in the United States ...
Breaking Biology Technology:Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3
... The IN VIVO Blog , which provides news, insights and ... a Deal of the Year for 2008 -- ... than 2,500 reader votes were cast in this inaugural competition, ... the 13 nominees selected by The IN VIVO Blog,s writers ...
... ALTOS, Calif., Jan. 8 InteKrin Therapeutics, Inc.,will present ... at,9:00 a.m. Pacific Time on Tuesday, January 13, 2009, ... Francisco, California. InteKrin Therapeutics, President and,CEO Denny Lanfear will ... About InteKrin ( http://www.InteKrin.com ): , ...
... Jan. 8 AcelRx Pharmaceuticals, Inc.,announced today it ... Clinical,Development. In this new position, Dr. Skowronski ... protocols and providing medical input,and review of clinical ... Pamela,Palmer, the company,s Chief Medical Officer. , ...
Cached Biology Technology:The IN VIVO Blog Selects First Annual 'Deal of the Year' 2InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13 2
(Date:7/2/2015)... Fingerprint Cards has received an order ... from the distributor World Peace Industrial Group (WPI), part of ... Asia . Deliveries are planned to take place ... by smartphone manufacturers in Asia . The ... revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... create tiny pools without walls with programmable microfluidic ... or traditional pressure methods to move microscopic amounts ... As just published as the cover story in ... electrowetting channels: electronic liquid transport with continuous channel ...
... 23, 2010 Age and gender play a major role ... study on 20-to-64-year-olds. Published in the journal Psychophysiology , ... Montral and the Montreal Heart Institute in collaboration with colleagues ... "Our findings suggest that women who are more defensive ...
... , March 23 Today, Texas Instruments Incorporated ... Fingerprint Development Kit, a complete signal chain solution at only ... features in reduced time to market.  This robust development kit ... processor (DSP), two widely-used sensor types (swipe and optical), as ...
Cached Biology News:A lab-on-a-chip with moveable channels 2Men and women respond differently to stress 2Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 2Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 3Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 4Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 5Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments' comprehensive, low cost fingerprint development kit 6
...
... Speed Rocker, with 12" x 14" table; 115V ... 14" table; 220V. The VSR-50 Variable Speed ... any lab. The VSR-50 provides a rhythmic side-to-side ... gentle to vigourous movement. This makes it ideal ...
...
... a 96-well ELISA-compatible plate (containing 12 x 8-well ... Antibody is immobilized by a method that retains ... tail fiber protein of the T7 bacteriophage. This ... 9 phage per well and low non-specific ...
Biology Products: